Cell Point (India) (NSE:CELLPOINT) PE Ratio without NRI: 441.18 (As of Jun. 30, 2026) — 1281% Above Median


NSE:CELLPOINT Cell Point (India) Ltd NSE:CELLPOINT
71 GF Score
Price ₹15.00
GF Value ₹34.72
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cell Point (India) PE Ratio without NRI?

Cell Point (India) NSE:CELLPOINT 71 PE Ratio without NRI is 441.18 as of Jun. 30, 2026, which is 1281% above its 10-year median of 31.94. GuruFocus rates NSE:CELLPOINT with a GF Score™ of 71/100 and a GF Value™ of ₹34.72 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 806 Retail - Cyclical companies, Cell Point (India) ranks worse than 97.89% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-06-30), Cell Point (India)'s share price is ₹15.00. Cell Point (India)'s EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.03. Therefore, Cell Point (India)'s PE Ratio without NRI for today is 441.18.

During the past 7 years, Cell Point (India)'s highest PE Ratio without NRI was 500.00. The lowest was 8.61. And the median was 31.94.

Cell Point (India)'s EPS without NRI for the six months ended in Mar. 2026 was ₹-0.07. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.03.

As of today (2026-06-30), Cell Point (India)'s share price is ₹15.00. Cell Point (India)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.03. Therefore, Cell Point (India)'s PE Ratio (TTM) for today is 441.18.

During the past years, Cell Point (India)'s highest PE Ratio (TTM) was 500.00. The lowest was 8.93. And the median was 15.58.

Cell Point (India)'s EPS (Diluted) for the six months ended in Mar. 2026 was ₹-0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.03.

Cell Point (India)'s EPS (Basic) for the six months ended in Mar. 2026 was ₹-0.07. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.03.


Cell Point (India)  (NSE:CELLPOINT) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Cell Point (India) PE Ratio without NRI Related Terms


Cell Point (India) PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Cell Point (India)'s PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Point (India) PE Ratio without NRI Chart

Cell Point (India) Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
PE Ratio without NRI
Get a 7-Day Free Trial N/A N/A 29.25 79.35 352.94

Cell Point (India) Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 29.25 At Loss 79.35 At Loss 352.94

NSE:CELLPOINT vs CASY, WSM, DKS: PE Ratio without NRI Comparison

For the Specialty Retail subindustry, Cell Point (India)'s PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell Point (India) PE Ratio without NRI vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Cell Point (India)'s PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Cell Point (India)'s PE Ratio without NRI falls into.


NSE:CELLPOINT
71GF Score
Cell Point (India) Ltd NSE:CELLPOINT
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cell Point (India) PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Cell Point (India)'s PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=15.00/0.034
=441.18

Cell Point (India)'s Share Price of today is ₹15.00.
For company reported semi-annually, Cell Point (India)'s EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 441.18 mean?
Cell Point (India) (NSE:CELLPOINT) has a PE Ratio without NRI of 441.18 as of Jun. 30, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Cell Point (India) and its competitors. This is 1281% above median its historical median of 31.94. Over the past decade, Cell Point (India)'s PE Ratio without NRI has ranged from 8.61 to 500.00. According to the industry distribution chart, Cell Point (India) ranks #789 out of 806 companies in the Retail - Cyclical industry, placing it in the top 97.9%.
Is Cell Point (India)'s PE Ratio without NRI too high?
Cell Point (India)'s current PE Ratio without NRI of 441.18 is 1281% above median its 10-year median of 31.94. Over the past 10 years, this metric has ranged from a low of 8.61 to a high of 500.00. The Retail - Cyclical industry median PE Ratio without NRI is 16.73. Cell Point (India)'s value of 441.18 is 2537.1% above this industry median. Based on the distribution chart, Cell Point (India) ranks #789 out of 806 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Cell Point (India) has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s PE Ratio without NRI compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Cell Point (India) ranks #789 out of 806 companies for PE Ratio without NRI. This places Cell Point (India) in the lower half of its industry. The industry median PE Ratio without NRI is 16.73. Cell Point (India)'s value of 441.18 is 2537.1% above this benchmark. Historically, Cell Point (India)'s own PE Ratio without NRI has ranged from 8.61 to 500.00 over the past decade. While the company's 10-year median is 31.94 vs. the industry median of 16.73, Cell Point (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Retail - Cyclical company?
The median PE Ratio without NRI among Retail - Cyclical companies is 16.73, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cell Point (India)'s current PE Ratio without NRI of 441.18 is 2537.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Cell Point (India) and its competitors. For the Retail - Cyclical industry, the median PE Ratio without NRI is 16.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Point (India)'s current PE Ratio without NRI is 441.18, which is 1281% above median its own 10-year median of 31.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹34.72, compared to a current price of ₹15.00 — trading 56.8% below its estimated fair value. The current PE Ratio without NRI is 441.18, which is 1281% above median its 10-year median of 31.94 and 2537.1% above the Retail - Cyclical industry median of 16.73. Cell Point (India)'s overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current PE Ratio without NRI is 441.18 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued. The current stock price of ₹15.00 is trading 56.8% below its estimated GF Value™ of ₹34.72. GuruFocus considers Cell Point (India) to be Significantly Undervalued.

Key valuation signals for NSE:CELLPOINT:

  • PE Ratio without NRI: 441.18 (1281% above median its 10-year median of 31.94)
  • GF Value™: ₹34.72 vs. price of ₹15.00 (56.8% below fair value)
  • GF Score™: 71/100 with 6 warning signs
  • Industry Position: 2537.1% above the Retail - Cyclical median (#789 of 806)

No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cell Point (India) Business Description

Address Lalitha Colony, Door No. 30-15-134, Dabagardens, Visakhapatnam, AP, IND, 530020
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
71GF Score

Get the complete analysis for NSE:CELLPOINT

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.00
Price
₹34.72
GF Value